The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is still trading at three-year highs, despite current market volatility, in ...

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...

Company to present updated preliminary results from ENLIGHTED Phase 3 Study in LG UTUC -- Additional podium presentation to provide updates ...

Pipeline and key clinical candidates for these companies: Arvinas is a clinical-stage biotechnology company that says it is “dedicated to improving the lives of patients suffering from ...

PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report) dropped 5.3% during trading on Thursday . The company traded as low as $1.23 and last traded at $1.25. Approximately 18,546 shares changed ...

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza ...

For those interested in investing in biotech companies, the best-performing small-cap biotech stocks are outlined below. Data was gathered on March 31, 2025, using TradingView’s stock screener.